PTCT
NASDAQ
$68.23
PTC Therapeutics Inc (PTCT)
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders. The company is headquartered in South Plainfield, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $91.57 (+34.21%)
Market Cap
$5.86B
PEG Ratio
0.81
Free Cash Flow Yield
-3.86%
Beta (5Y)
1.05
Price Chart
Valuation
Market Cap$5.86B
Forward P/E53.48
PEG0.81
P/S7.41
P/B1743.27
Profitability
Total Revenue (TTM)$827M
Gross Profit (TTM)$306M
EBITDA-$11M
Profit Margin-1%
Operating Margin16.5%
EPS-$2.31
Financial Health
Debt-to-Equity-159%
Free Cash Flow Yield-3.86%
Growth & Risk
EPS 5Y CAGR-16.59%
Revenue 5Y CAGR+13.95%
FCF 5Y CAGR-0.34%
Beta (5Y)1.05
Sharpe Ratio0.94